迈瑞医疗 (300760)
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 121244.14
- Circulating A-Shares(W): 121240.56
- Earnings Per Share(RMB): 6.2481
- Net Assets Per Share(RMB): 32.4120
- Operating Revenue(W RMB): 2583390.65
- Total Profit(W RMB): 890161.18
- Net Profit Attributable to Parent(W RMB): 757004.45
- Net Profit Growth Rate(%): -28.83
- Weighted Return on Equity(%): 19.6400
- Operating Cash Flow Per Share(RMB): 5.9990
- Undistributed Profit Per Share(RMB): 25.7450
- Capital Reserve Per Share(RMB): 5.0325
2. Main Business
The main business covers:
- R&D of medical devices
- Manufacturing of medical devices
- Marketing of medical devices
- Service for medical devices
3. Company Basic Information
- Company Name: Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Listing Date: 2018-10-16
- Industry: Special Purpose Equipment Manufacturing
- Address: 1-4/F, Mindray Building, South 12th Road, High-tech Industrial Park, Nanshan District, Shenzhen, Guangdong Province
- Website: www.mindray.com
- Company Profile: The company was established through the overall restructuring of Mindray Limited into a joint stock company. On October 17, 2001, Shenzhen Tianjian Xinde Certified Public Accountants issued the "Audit Report" (Xinde Shen Te Shen Bao Zi (2001) No. 56), verifying that as of July 31, 2001, the net assets of Mindray Limited were 86,265,839.55 yuan. On October 18, 2001, the board of directors of Mindray Limited passed a resolution on the establishment of a joint stock company by promotion, agreeing to change Mindray Limited into a joint stock company by way of promotion. The audited net assets of Mindray Limited as of July 31, 2001, amounting to 86,265,839.55 yuan, were converted into 86,000,000 shares of Mindray Medical (with a par value of RMB 1 per share), with the difference of 265,839.55 yuan recorded as capital reserve. All shareholders of Mindray Limited, as promoters, subscribed for the shares of the joint stock company with the net assets corresponding to their respective equity interests in Mindray Limited. On December 18, 2001, the company held its inaugural meeting and first shareholders' meeting, which reviewed and approved the relevant proposals for the overall change of Mindray Limited into a joint stock company. The meeting also reviewed and approved the new articles of association and matters related to the company's establishment, and elected the directors of the first board of directors and the shareholder representative supervisors of the first board of supervisors. On December 26, 2001, the Shenzhen Administration for Industry and Commerce issued the "Business License of Enterprise Legal Person" for the change to a joint stock company.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Smartco Development Limited | Legal Person | 32707.23 | 26.98 |
| 2 | Magnifice(HK)Limited | Legal Person | 29695.10 | 24.49 |
| 3 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 11666.51 | 9.62 |
| 4 | Ever Union(H.K.)Limited | Legal Person | 4648.24 | 3.83 |
| 5 | E Fund ChiNext Board ETF | Fund | 1169.35 | 0.96 |
| 6 | Huatai-PineBridge CSI 300 ETF | Fund | 1033.58 | 0.85 |
| 7 | HuaBao CSI Medical ETF | Fund | 947.20 | 0.78 |
| 8 | National Social Security Fund 113 Portfolio | Social Security Fund | 772.53 | 0.64 |
| 9 | E Fund CSI 300 Healthcare ETF | Fund | 759.59 | 0.63 |
| 10 | Invesco Great Wall Emerging Growth Hybrid Fund A | Fund | 748.00 | 0.62 |
5. Concept Sectors
- Tongdaxin 88
- AIGC Concept
- Pulse Oximeter
- Pet Economy
- DeepSeek
- AI Healthcare
- Margin Trading
- Large Cap Stock
- High-Performance Stock
- Social Security Fund Heavy Position
- Fund Heavy Position
- Industry Leader
- Recent Low
- Hundred-Yuan Stock
- MSCI Constituent
- Social Security Fund New Entry
- Northbound Heavy Position
- Mainland-Hong Kong Stock Connect Heavy
- Non-Cyclical Stock
- High Dividend Stock
- Commitment Not to Reduce
- CSI 100
- Galaxy 99
- Zhongchuang 100
- Large Cap Growth
- ChiNext Index
- SZSE 100
- SZSE 300
- SZSE Dividend
- SZSE Governance
- Consumption 100
- SZSE Governance Index
- SZSE Growth Index
- SZSE Growth
- CSI 300
- ChiNext 50
- China A80
- ChiNext 300
- 300 Non-Cyclical
- CSI Leaders
- SZSE Innovation
- ChiNext Innovation
- ChiNext Blue Chip
- ChiNext Large Cap
- FTSE A50
- ChiNext Technology
- ChiNext Healthcare
- STAR 50
- Innovation 100
- 300 ESG
- MSCI China A50
- Pearl River Delta
- SZSE 50
- CSI A50
- CSI A100
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information
